Association between common genetic variants in pre-microRNAs and the clinicopathological characteristics and survival of gastric cancer patients

Experimental and Therapeutic Medicine

Volumn 1, Issue 6, 2010, Pages 1035-1040

  Okubo, Masaaki ^a   Tahara, Tomomitsu ^a   Shibata, Tomoyuki ^a   Yamashita, Hiromi ^a   Nakamura, Masakatsu ^a   Yoshioka, Daisuke ^a   Yonemura, Joh ^a   Kamiya, Yoshio ^a   Ishizuka, Takamitsu ^a   Nakagawa, Yoshihito ^a   Nagasaka, Mitsuo ^a   Iwata, Masami ^a   Arisawa, Tomiyasu ^b   Hirata, Ichiro ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

CpG island hypermethylation; Gastric cancer; Helicobacter pylori; Mir 146a; Mir 196a2; Polymorphism; Pre microRNAs; Rs11614913; Rs2910164

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; MICRORNA; PROTEIN P14; PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER SURVIVAL; CLINICAL FEATURE; CPG ISLAND; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYPLOIDY; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

EID: 78049236190     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.154     Document Type: Article

References (34)

1. Parkin DM, Whelan SL, Ferlay J, raymond I and young J: Cancer incidence in Five continents. Volume Vii. iarc press, lyon, 1997.
2. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. int J cancer 80: 827-841, 1999.
3. Lagos-Quintana M, Rauhut R, Lendeckel W and Tuschl T: Identification of novel genes coding for small expressed RNAs. Science 294: 853-858, 2001.
4. Lau NC, Lim LP, Weinstein EG and Bartel DP: An abundant class of tiny rnas with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862, 2001.
5. Lee RC and Ambros V: An extensive class of small rnas in Caenorhabditis elegans. Science 294: 862-864, 2001.
6. Ambros V: MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. cell 113: 673-676, 2003.
7. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. nature 435: 834-838, 2005.
8. Esquela-Kerscher A and Slack FJ: Oncomirs - micrornas with a role in cancer. nat rev cancer 6: 259-269, 2006.
9. Kumar MS, Lu J, Mercer KL, Golub TR and Jacks T: Impaired microrna processing enhances cellular transformation and tumorigenesis. nat Genet 39: 673-677, 2007.
10. Petrocca F, Visone R, Onelli MR, et al: E2F1-regulated micrornas impair tGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. cancer cell 13: 272-286, 2008.
11. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N and Akao Y: Decreased expression of microrna-143 and -145 in human gastric cancers. Oncology 77: 12-21, 2009.
12. Hu Z, Chen J, Tian T, et al: Genetic variants of mirna sequences and non small cell lung cancer survival. J clin invest 118: 2600-2608, 2008.
13. Tian T, Shu Y, Chen J, et al: A functional genetic variant in microrna-196a2 is associated with increased susceptibility of lung cancer in chinese. cancer Epidemiol biomarkers prev 18: 1183-1187, 2009.
14. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR and de la Chapelle A: Common Snp in pre-mir-146a decreases mature mir expression and predisposes to papillary thyroid carcinoma. proc natl acad Sci uSa 105: 7269-7274, 2008.
15. Xu T, Zhu Y, Wei QK, et al: A functional polymorphism in the mir-146a gene is associated with the risk for hepatocellular carcinoma. carcinogenesis 29: 2126-2131, 2008.
16. Hu Z, Liang J, Wang Z, et al: Common genetic variants in premicrornas were associated with increased risk of breast cancer in chinese women. hum mutat 30: 79-84, 2009.
17. Peng S, Kuang Z, Sheng C, et al: Association of microrna- 196a-2 gene polymorphism with gastric cancer risk in a chinese population. dig dis Sci 55: 2288-2293, 2010.
18. Tahara T, Shibata T, Arisawa T, et al: Cpg island promoter methylation (cihm) status of tumor suppressor genes correlates with morphological appearances of gastric cancer. anticancer res 30: 239-244, 2010.
19. Tahara T, Shibata T, Nakamura M, et al: Association between cyclin d1 polymorphism with CpG island promoter methylation status of tumor suppressor genes in gastric cancer. dig dis Sci: april 16, 2010 (E-pub ahead of print).
20. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
21. Gotoda T, Yanagisawa A, Sasako M, et al: Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric cancer 3: 219-225, 2000.
22. Toyota M, Ahuja N, Suzuki H, et al: Aberrant methylation in gastric cancer associated with the cpG island methylator phenotype. cancer res 59: 5438-5442, 1999.
23. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY and Rhyu MG: CpGisland methylation in premalignant stages of gastric carcinoma. cancer res 61: 2847-2851, 2001.
24. Chan AO, Lam SK, Wong BC, et al: Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 52: 502-506, 2003.
25. Raveh T and Kimchi A: Dap kinase - a proapoptotic gene that functions as a tumor suppressor. Exp cell res 264: 185-192, 2001.
26. Schildhaus HU, Krockel I, Lippert H, Malfertheiner P, Roessner A and Schneider-Stock R: Promoter hypermethyla- tion of p16inK4a, E-cadherin, O6-mGmt, dapK and Fhit in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach. int J Oncol 26: 1493-1500, 2005.
27. Waki T, tamura G, Sato M, Terashima M, Nishizuka S and Motoyama T: Promoter methylation status of dap-kinase and runx3 genes in neoplastic and non-neoplastic gastric epithelia. cancer Sci 94: 360-364, 2003.
28. Kang Gh, Lee HJ, Hwang KS, Lee S, Kim Jh and Kim JS: Aberrant CpGisland hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 163: 1551-1556, 2003.
29. Song SY, Kim S, Kim DS, Son HJ, Rhee JC and Kim YI: Abnormal expression of E-cadherin in early gastric carcinoma: its relationship with macroscopic growth patterns and catenin alpha and beta. J clin Gastroenterol 38: 252-259, 2004.
30. Namieno T, Koito K, Higashi T, Takahashi M, Yamashita K and Kondo Y: Assessing the suitability of gastric carcinoma for limited resection: endoscopic prediction of lymph node metas- tases. World J Surg 22: 859-864, 1998.
31. Tahara T, Arisawa T, Shibata T, et al: Increased number of methylated CpGislands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis. Eur J Gastroenterol hepatol 21: 613-619, 2009.
32. Tahara T, Shibata T, Nakamura M, et al: Increased number of cpG island hypermethylation in tumor suppressor genes of non- neoplastic gastric mucosa correlates with higher risk of gastric cancer. digestion 82: 27-36, 2010.
33. Zhang KL, Sun Y, Li Y, et al: Increased frequency of CpG island methylator phenotype and cdh1 methylation in a gastric cancer high-risk region of china. transl Oncol 1: 28-35, 2008.
34. Luo D, Zhang B, Lv L, et al: Methylation of cpG islands of p16 associated with progression of primary gastric carcinomas. lab invest 86: 591-598, 2006.